External Oblique Intercostal Plane Block for Postoperative Analgesia After Major Upper Abdominal Surgery
External Oblique Intercostal Plane Block for Postoperative Analgesia After Major Upper Abdominal Surgery: A Randomized Controlled Trial
Jun Zhang
78 participants
Feb 1, 2026
INTERVENTIONAL
Conditions
Summary
Postoperative pain after laparoscopic major upper abdominal surgery (e.g., gastric, hepatic, gallbladder, pancreatic surgery) is often severe, and inadequate analgesia may lead to increased opioid use, opioid dependence, and poor functional recovery. Current analgesic techniques such as neuraxial block have safety concerns (e.g., hypotension, neurological injury), while transversus abdominis plane (TAP) block is ineffective for blocking the lateral cutaneous branches of intercostal nerves in the upper abdomen. The External Oblique Intercostal Plane Block (EOIB) is a novel regional block technique that has shown promise in reducing postoperative opioids and pain in small-scale studies, but evidence for its use in major upper abdominal surgery is limited. This randomized controlled trial (RCT) aims to evaluate the analgesic efficacy and safety of bilateral EOIB combined with standard multimodal analgesia versus standard multimodal analgesia alone in patients undergoing elective laparoscopic major upper abdominal surgery. The primary outcome is the total postoperative opioid consumption (measured as Morphine Milligram Equivalents, MME) within 24 hours. Secondary and additional outcomes include pain scores (Verbal Rating Scale, VRS), recovery quality (QoR-15 scale), incidence of adverse events, and hospital stay.
Eligibility
Inclusion Criteria6
- Obtain written informed consent from participants or their legal representatives
- Age between 18 and 85 years
- American Society of Anesthesiologists (ASA) physical status classification I-III
- Scheduled for elective laparoscopic major upper abdominal surgery (e.g., gastric, hepatic, gallbladder, pancreatic surgery)
- Expected surgical duration ≥ 2 hours
- Ability to use the intravenous patient-controlled analgesia (IV PCA) system
Exclusion Criteria7
- Hepatic disease (liver enzyme levels ≥ 2× the upper limit of normal)
- Renal disease (serum creatinine levels ≥ 2× the upper limit of normal)
- Allergy to local anesthetics or known study-related drugs
- Pregnancy or lactation
- Low surgical incision site (not involving the upper abdominal wall innervated by T6-T10 nerves)
- Coagulopathy or current use of anticoagulant medications
- Opioid use for more than 2 weeks in the past 6 months
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Ultrasound-guided bilateral external oblique intercostal plane block (EOIB) performed after induction of general anesthesia and before surgical incision. Using an in-plane technique at the 6th rib level, 15 mL per side of local anesthetic solution (ropivacaine 0.75% diluted with normal saline) is injected between the external oblique muscle and the intercostal muscle. Standard multimodal analgesia is also provided to all participants.
Standard multimodal analgesia per institutional ERAS practice, including intravenous patient-controlled analgesia (IV PCA) with opioids and adjunct non-opioid analgesics (e.g., NSAIDs and/or acetaminophen) with antiemetic prophylaxis as needed. No regional block is administered.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07331441